How hospitals can manage anticoagulant-related acute major bleeding


Thursday, September 12th, 2024 | 11:00 AM - 12:00 PM CT

While anticoagulants are vital in preventing thrombotic events, their use carries inherent risks, including the potential for uncontrolled bleeding. Over 500 patients a day are hospitalized for acute major bleeding in the U.S., about 90 of whom die from the complication. 

This webinar, featuring a pharmacy professor from University of Nebraska Medical Center in Omaha, will offer best practices for hospitals to manage uncontrolled bleeding related to factor Xa inhibitors, including the value of reversal agents.

Learning points:
 
  • Review the top-line results of a prospective, randomized clinical trial in patients with ICH taking apixaban or rivaroxaban.
  • Discuss clinical trials and real-world evidence studies of this reversal agent for apixaban and rivaroxaban in patients with acute major bleeding.

Presenter:

Paul P. Dobesh, Pharm.D., FACC, FAHA, FCCP, BCPS, BCCP

Professor of Pharmacy Practice and Science,
College of Pharmacy
University of Nebraska Medical Center
.

 

By registering, you agree to Becker's Healthcare terms of service and privacy policy.

I would like to also add the following learning opportunities to my registration:

  • Behavioral health is under pressure. How some leaders are cutting claims denials by 25% — here. - January 29th at 12:00 PM CT - Learn Now
  • Cedars-Sinai, Carle Health + more reveal a blueprint for AI adoption and driving ROI, here. - February 6th at 1:00 PM CT - Learn Now
  • Finding top talent shouldn't be hard. How system leaders are streamlining recruitment, here. - February 20th at 12:00 PM CT - Learn Now
  • Learn 6 common areas where health systems need support during a Workday transformation — here. - Read Now
  • Dental + DSO Virtual Event - Thursday, January 23rd, 2025 - Learn Now